Health Canada has traditionally relied upon manufacturers, doctors and ordinary Canadians to submit adverse drug reaction reports, but a report from the Senate social affairs committee published last month notes they likely represent no more than 5 per cent of the total side effects experienced by patients outside clinical trials.